Overall, the global vascular access device market was valued at $4.2 billion, with around 1 billion vascular access devices placed each year. The market size is expected to increase over the forecast period and reach $4.8 billion in 2026. HOW ARE VASCULAR ACCESS DEVICES USED? iData’s global market report for vascular access devices includes both
iData’s report on the global central venous catheter (CVC) market includes both acute and chronic CVC’s. In the past, the central venous catheter market suffered extreme consequences after the Joint Commission guidelines recommended that catheters should only be placed in the femoral vein if no other sites are available. This recommendation was due to the
Canada’s vascular access market includes medical devices with the ability to access a patient’s veins and arteries as well as accessories to improve safety and performance. By 2026, Canada’s vascular access market expects to reach $352.5 million at a CAGR of 2%. Overall, there are many vascular access devices, and iData’s analysis includes a wide
What are Central Venous Catheters? In emergency and non-emergency situations, central venous catheters, in short, CVCs, gain immediate high-flow vascular access. Because of the higher potential flow rates, veins with larger diameters such as the jugular, subclavian, and femoral veins are the best for CVCs as they accommodate more lumens. In situations where patients require
Based on the latest market analysis by iData Research, the European Transcatheter Aortic Valve Replacement (also known as TAVR/TAVI) market was valued at €836.2 million in 2020, which is a 29% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace the diseased aortic valve in patients with severe aortic stenosis.
As we progress through the global pandemic and drive closer to having a vaccine available, companies are now preparing supplies such as needles and syringes. We have compiled the top three companies to watch as distributors for needles and syringes in the United States. Becton Dickinson Cardinal Health Novo Nordisk Becton Dickinson Becton Dickinson produces
Teleflex has announced its receival of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for the use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device is used to provide procedural guidance within the establishment of intraosseous vascular access, especially when intravenous access is difficult to obtain in
According to the latest vascular access device market analysis by iData Research, there are over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year in the United States. The overall US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. PICC insertions
According to the latest market analysis by iData Research, the US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. One of the biggest contributors to this growth will be the PICC, CVC, and PIVC line insertion and securement accessories market. This market growth is primarily
Welcome to the analyst interview series where we take a closer look at specific markets and try to understand how they are being impacted by the COVID-19 virus. Through asking our market analysts a series of questions, we attempt to get an in-depth look at the current state of the market while uncovering critical market
